CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 227 enrolled
Drug / intervention
Pharmacogenomic algorithmother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01610063
NCT01610063N/ACompleted
CompareCT.gov

A Pilot Study for the Evaluation of the Clinic-wide Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting

Mayo Clinic·interventional·Posted Jun 1, 2012·Updated Mar 30, 2017

In Brief

A clinical study evaluating Pharmacogenomic algorithm for Depression. Completed, enrolled 227 participants across 1 site.

Detailed Summary

This was a study of a genotyping tool that reported on how subjects responded to medications and could be used in a community psychiatry practice to improve medication choice for depression. After the DNA test, an interpretive report was provided to the subjects' physicians. The hypothesis of this pilot study was that it was feasible to use this pharmacogenomic algorithm in a new setting to treat depressed subjects..

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsAssurex Health Home

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 1, 2012
Enrollment StartJan 1, 2009
Primary CompletionNov 1, 2011
Study CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 14.1 years ago

Interventions

Pharmacogenomic algorithmother

Genetic test results for 4 genes were put through algorithm and provided to physician for guidance prescribing medication.